TW202233652A - 以雞貧血病毒(cav)為主之載體 - Google Patents

以雞貧血病毒(cav)為主之載體 Download PDF

Info

Publication number
TW202233652A
TW202233652A TW110140471A TW110140471A TW202233652A TW 202233652 A TW202233652 A TW 202233652A TW 110140471 A TW110140471 A TW 110140471A TW 110140471 A TW110140471 A TW 110140471A TW 202233652 A TW202233652 A TW 202233652A
Authority
TW
Taiwan
Prior art keywords
cav
nucleic acid
genetic element
sequence
vector
Prior art date
Application number
TW110140471A
Other languages
English (en)
Chinese (zh)
Inventor
賽門 德拉葛瑞夫
費爾南多 馬汀 迪亞茲
傑拉德 大衛 皮滋
凱文 詹姆斯 李伯
喬瑟夫 路易斯 廷波納
妮可 瑪莉 波依斯維特
Original Assignee
美商旗艦先鋒創新公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商旗艦先鋒創新公司 filed Critical 美商旗艦先鋒創新公司
Publication of TW202233652A publication Critical patent/TW202233652A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/00043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TW110140471A 2020-10-29 2021-10-29 以雞貧血病毒(cav)為主之載體 TW202233652A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063107149P 2020-10-29 2020-10-29
US63/107,149 2020-10-29
US202163147087P 2021-02-08 2021-02-08
US63/147,087 2021-02-08

Publications (1)

Publication Number Publication Date
TW202233652A true TW202233652A (zh) 2022-09-01

Family

ID=81384465

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110140471A TW202233652A (zh) 2020-10-29 2021-10-29 以雞貧血病毒(cav)為主之載體

Country Status (10)

Country Link
US (1) US20240000914A1 (https=)
EP (1) EP4237567A4 (https=)
JP (1) JP2023548838A (https=)
KR (1) KR20230093326A (https=)
AU (1) AU2021372533A1 (https=)
CA (1) CA3199750A1 (https=)
IL (1) IL302332A (https=)
MX (1) MX2023005040A (https=)
TW (1) TW202233652A (https=)
WO (1) WO2022094238A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113897356A (zh) * 2021-10-20 2022-01-07 佛山科学技术学院 一种检测鸡传染性贫血病毒荧光定量pcr试剂盒及引物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250027107A1 (en) 2021-10-18 2025-01-23 Flagship Pioneering Innovations Vii, Llc Dna compositions and related methods
TW202529819A (zh) 2023-10-13 2025-08-01 美商旗艦先鋒創新公司 組織特異性指環載體(anellovector)遞送

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030138443A1 (en) * 1993-03-08 2003-07-24 Noteborn Mathews H.M. Cloning of chicken anemia virus DNA
US5922600A (en) * 1990-09-12 1999-07-13 Leadd Bv Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor
US9862760B2 (en) * 2015-09-16 2018-01-09 Novartis Ag Polyomavirus neutralizing antibodies
GB201701239D0 (en) * 2017-01-25 2017-03-08 Glaxosmithkline Biologicals Sa Novel formulation
KR20210131309A (ko) * 2018-12-12 2021-11-02 플래그쉽 파이어니어링 이노베이션스 브이, 인크. 분비형 치료 양식을 운반하기 위한 아넬로좀

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113897356A (zh) * 2021-10-20 2022-01-07 佛山科学技术学院 一种检测鸡传染性贫血病毒荧光定量pcr试剂盒及引物
CN113897356B (zh) * 2021-10-20 2024-04-30 佛山科学技术学院 一种检测鸡传染性贫血病毒荧光定量pcr试剂盒及引物

Also Published As

Publication number Publication date
IL302332A (en) 2023-06-01
AU2021372533A9 (en) 2024-07-11
WO2022094238A2 (en) 2022-05-05
EP4237567A4 (en) 2025-01-15
WO2022094238A3 (en) 2022-06-09
MX2023005040A (es) 2023-06-02
CA3199750A1 (en) 2022-05-05
JP2023548838A (ja) 2023-11-21
US20240000914A1 (en) 2024-01-04
AU2021372533A1 (en) 2023-06-01
EP4237567A2 (en) 2023-09-06
KR20230093326A (ko) 2023-06-27

Similar Documents

Publication Publication Date Title
CN111372943B (zh) 腺病毒及其用途
US20250382349A1 (en) Compositions and Methods for Retrieving Tumor-related Antibodies and Antigens
TW202233652A (zh) 以雞貧血病毒(cav)為主之載體
KR102077131B1 (ko) 치쿤구니야 바이러스 폴리펩티드를 발현하는 재조합 홍역 바이러스 및 이의 사용
KR101522217B1 (ko) Ｆｓｈ 제조 세포 클론
US20100285592A1 (en) Single expression vector for generation of a virus with a segmented genome
JP2023509964A (ja) 真核生物翻訳可能ｍＲＮＡの生成および真核生物への送達のための微生物システム
KR101320489B1 (ko) 인간 세포주에서 재조합 인간 단백질의 무혈청의 안정한형질감염 및 생산
CN114174324A (zh) 用于溶酶体病症的基因疗法
KR102335519B1 (ko) 인체 감염 사스코로나 바이러스 예방 및 감염 증상 완화용 백신 조성물
US20230227849A1 (en) Methods of identifying and characterizing anelloviruses and uses thereof
US20250213725A1 (en) Novel anelloviridae family vector compositions and methods
TW202223095A (zh) 串聯指環病毒構築體
CN113584062B (zh) 融合成像基因及其慢病毒表达质粒、慢病毒、细胞，其制备方法和用途
CN110373427A (zh) 一种人源tlr4基因3′非翻译区的双荧光素酶报告基因载体及其构建方法与应用
CN113652451B (zh) 慢病毒载体、构建方法及其应用
CN116324408A (zh) 分泌α-突触核蛋白靶向抗体、颗粒蛋白前体和鞘脂激活蛋白原及两者的复合物以及GDNF的细胞系
US20240408241A1 (en) Novel anellovector compositions and methods
US20240254512A1 (en) Anellovectors and methods of use
CN114703207A (zh) 重组质粒的制备方法和重组病毒
CN111100841B (zh) 抗肥胖药物靶点ucp1的基因工程细胞株和高通量药物筛选模型的建立及应用
CN114874332A (zh) 经修饰的rnf112作为治疗als药物的应用
CN114058607B (zh) 一种用于c到u碱基编辑的融合蛋白及其制备方法和应用
CN120168624B (zh) 一种伪狂犬免疫原组合物及其用途
KR20110017146A (ko) 인터루킨-10 억제용 ｓｉＲＮＡ, 그를 포함하는 조성물 및 세포